{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:56:44Z","timestamp":1768636604375,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T00:00:00Z","timestamp":1472774400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00198-016-3761-x","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T07:28:28Z","timestamp":1472801308000},"page":"3655-3659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report"],"prefix":"10.1007","volume":"27","author":[{"given":"A.","family":"Catalano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"3761_CR1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","volume":"12","author":"M Eagle","year":"2002","unstructured":"Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12:926\u2013929","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"3761_CR2","first-page":"CD003725","volume":"5","author":"E Matthews","year":"2016","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY (2016) Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev 5(5):CD003725","journal-title":"Cochrane Database Syst Rev"},{"key":"3761_CR3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00198-010-1275-5","volume":"22","author":"ML Bianchi","year":"2010","unstructured":"Bianchi ML, Morandi L, Andreucci E, Vai S, Frasunkiewicz J, Cottafava R (2010) Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment. Osteoporos Int 22:529\u2013539","journal-title":"Osteoporos Int"},{"issue":"2","key":"3761_CR4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00198-013-2442-2","volume":"25","author":"S Pouwels","year":"2014","unstructured":"Pouwels S, de Boer A, Leufkens HG, et al. (2014) Risk of fracture in patients with muscular dystrophies. Osteoporos Int 25(2):509\u2013518","journal-title":"Osteoporos Int"},{"key":"3761_CR5","doi-asserted-by":"crossref","unstructured":"Ferrari S, Bianchi ML, Eisman JA, et al. (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int:2735\u20132748","DOI":"10.1007\/s00198-012-2030-x"},{"key":"3761_CR6","first-page":"71","volume":"20","author":"CM Larson","year":"2000","unstructured":"Larson CM, Henderson RC (2000) Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 20:71\u201374","journal-title":"J Pediatr Orthop"},{"issue":"20","key":"3761_CR7","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag KG, Shane E, Boonen S, et al. (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357(20):2028\u20132039","journal-title":"N Engl J Med"},{"issue":"3","key":"3761_CR8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bone.2012.05.003","volume":"51","author":"SK Gray","year":"2012","unstructured":"Gray SK, McGee-Lawrence ME, Sanders JL, Condon KW, Tsai CJ, Donahue SW (2012) Black bear parathyroid hormone has greater anabolic effects on trabecular bone in dystrophin-deficient mice than in wild type mice. Bone 51(3):578\u2013585","journal-title":"Bone"},{"key":"3761_CR9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","volume":"51","author":"G Apolone","year":"1998","unstructured":"Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025\u20131036","journal-title":"J Clin Epidemiol"},{"key":"3761_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-006-0019-1","volume":"79","author":"TP Staa van","year":"2006","unstructured":"van Staa TP (2006) The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 79:129\u2013137","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"3761_CR11","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","volume":"23","author":"S Lekamwasam","year":"2012","unstructured":"Lekamwasam S, Adachi JD, Agnusdei D, et al. (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23(9):2257\u20132276","journal-title":"Osteoporos Int"},{"key":"3761_CR12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","volume":"102","author":"RS Weinstein","year":"1998","unstructured":"Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274\u2013282","journal-title":"J Clin Invest"},{"issue":"19","key":"3761_CR13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, et al. (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434\u20131441","journal-title":"N Engl J Med"},{"issue":"13","key":"3761_CR14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"349","author":"JS Finkelstein","year":"2003","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349(13):1216\u20131226","journal-title":"N Engl J Med"},{"issue":"1","key":"3761_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-004-0083-3","volume":"6","author":"C Deal","year":"2004","unstructured":"Deal C (2004) The use of intermittent human parathyroid hormone as a treatment for osteoporosis. Curr Rheumatol Rep 6(1):49\u201358","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"3761_CR16","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/jbmr.530","volume":"26","author":"HP Arantes","year":"2011","unstructured":"Arantes HP, Barros ER, Kunii I, Bilezikian JP, Lazaretti-Castro M (2011) Teriparatide increases bone mineral density in a man with osteoporosis pseudoglioma. J Bone Miner Res 26(12):2823\u20132826","journal-title":"J Bone Miner Res"},{"issue":"3","key":"3761_CR17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00223-014-9926-8","volume":"96","author":"MN Meriggioli","year":"2015","unstructured":"Meriggioli MN, Roubenoff R (2015) Prospect for pharmacological therapies to treat skeletal muscle dysfunction. Calcif Tissue Int 96(3):234\u2013242","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"3761_CR18","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jbmr.100","volume":"25","author":"S Elis","year":"2010","unstructured":"Elis S, Courtland HW, Wu Y, et al. (2010) Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact. J Bone Miner Res 25(9):2051\u20132058","journal-title":"J Bone Miner Res"},{"key":"3761_CR19","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1038\/srep05066","volume":"4","author":"S Kimura","year":"2014","unstructured":"Kimura S, Yoshioka K (2014) Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation. Sci Rep 4:5066","journal-title":"Sci Rep"},{"issue":"2","key":"3761_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-005-2013-2","volume":"17","author":"MC Nevitt","year":"2006","unstructured":"Nevitt MC, Chen P, Dore RK, et al. (2006) Reduced risk of back pain following teriparatide treatment: a metaanalysis. Osteoporos Int 17(2):273\u2013280","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3761-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3761-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3761-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T21:50:17Z","timestamp":1498341017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3761-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3761"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3761-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]}}}